Clinical Trial Update: Capecitabine as NeoAdjuvant Therapy in Locally Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating capecitabine as neoadjuvant therapy in locally advanced breast cancer was terminated. The results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

Sponsor: University of Chicago | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2015-12-14